Stem Cell-Based Strategies: The Future Direction of Bioartificial Liver Development
The DOI matches its Crossref record; 213 of the 214 references it cites were found in a registry or an index.
Abstract
Acute liver failure (ALF) results from severe liver damage or end-stage liver disease. It is extremely fatal and causes serious health and economic burdens worldwide. Once ALF occurs, liver transplantation (LT) is the only definitive and recommended treatment; however, LT is limited by the scarcity of liver grafts. Consequently, the clinical use of bioartificial liver (BAL) has been proposed as a treatment strategy for ALF. Human primary hepatocytes are an ideal cell source for these methods. However, their high demand and superior viability prevent their widespread use. Hence, finding alternatives that meet the seed cell quality and quantity requirements is imperative. Stem cells with self-renewing, immunogenic, and differentiative capacities are potential cell sources. MSCs and its secretomes encompass a spectrum of beneficial properties, such as anti-inflammatory, immunomodulatory, anti-ROS (reactive oxygen species), anti-apoptotic, pro-metabolomic, anti-fibrogenesis, and pro-regenerative attributes. This review focused on the recent status and future directions of stem cell-based strategies in BAL for ALF. Additionally, we discussed the opportunities and challenges associated with promoting such strategies for clinical applications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This engineering environment mimics the structure of the liver and promotes the survival and proliferation of liver cells [38–40].”
From Constructing biomimetic microenvironments for liver regeneration (2025) · doi:10.1186/s12951-025-03729-9 · cites this paper as [38]
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673 · cited 3×
“Oct3/4, Sox2, Klf4, and c-Myc genes were selected for transfection during the initial iPSC construction [93, 94].”
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926 · cited 2×
“In the early period, original hESCs were isolated from the inner cell mass of the blastocysts of human embryos [53, 59], and the embryos were destroyed.”
International Journal of Molecular Sciences
(2024) · International Journal of Molecular Sciences · doi:10.3390/ijms · Cited by 10,111
Establishment in culture of pluripotential cells from mouse embryos
Evans, M. J., & Kaufman, M. H. (1981) · Nature · doi:10.1038/292154a0 · Cited by 8,607 · cited 1×
“It was first isolated from mouse embryos in 1981 [52], and later isolated from human intracellular blastocysts in 1998 [53].”
Human mesenchymal stem cells modulate allogeneic immune cell responses
Aggarwal, S., & Pittenger, M. F. (2005) · Blood · doi:10.1182/blood-2004-04-1559 · Cited by 4,511 · cited 1×
“According to Aggarwal et al., MSCs significantly inhibit the secretion of TNF-α by mature type 1 dendritic cells (DCs) and decrease the secretion of interferon-gamma (IFN-γ) by Th1 cells and NK cells [40].”
Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro
Reubinoff, B. E., Pera, M. F., Fong, C.-Y., Trounson, A., & Bongso, A. (2000) · Nature Biotechnology · doi:10.1038/74447 · Cited by 2,706
Growth Factors, Matrices, and Forces Combine and Control Stem Cells
Discher, D. E., Mooney, D. J., & Zandstra, P. W. (2009) · Science · doi:10.1126/science.1171643 · Cited by 2,667 · cited 1×
“The niche, which is a microenvironment of in vivo components and interactions, includes growth actors, cell–cell contacts, and cell–matrix adhesions that regulate ESCs survival, self-renewal, and differentiation [86].”
Warren, L., Manos, P. D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z. D., Meissner, A., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.012 · Cited by 2,662 · cited 1×
“Moreover, non-viral methods such as recombinant proteins [112, 113], mRNA transfection [114, 115], and non-coding microRNAs [116] have been used to induce iPSCs.”
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
Freed, C. R., Greene, P. E., Breeze, R. E., Tsai, W.-Y., DuMouchel, W., Kao, R., Dillon, S., Winfield, H., Culver, S., Trojanowski, J. Q., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441002 · Cited by 2,366
Cited by
Liver regeneration after injury: Mechanisms, cellular interactions and therapeutic innovations
Liu, Q., Wang, S., Fu, J., Chen, Y., Xu, J., Wei, W., Song, H., Zhao, X., & Wang, H. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1812 · Cited by 49
Bridging Therapies—Ex Vivo Liver Xenoperfusion and the Role of Machine Perfusion: An Update
Czigány, Z., Shirini, K., Putri, A. J., Longchamp, A., Bhusal, S., Kamberi, S. S., & Meier, R. P. H. (2025) · Xenotransplantation · doi:10.1111/xen.70011 · Cited by 21
Constructing biomimetic microenvironments for liver regeneration
(2025) · doi:10.1186/s12951-025-03729-9 · Cited by 11
“This engineering environment mimics the structure of the liver and promotes the survival and proliferation of liver cells [38–40].”
Bioartificial liver: Where lies the path ahead—A review
Jiang, Q., Su, Y., Cao, X., Zhang, H., Zhang, J., & Li, L. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000788 · Cited by 11
“[ 70 ] The limited tissue availability and ethical concerns associated with hepatic stem cells and embryonic stem cells severely hinder their clinical implementation.”
Qin, S., Bo, X., Liu, H., Zhang, Z., Zhao, Z., & Xia, Q. (2025) · Hepatology · doi:10.1097/hep.0000000000001321 · Cited by 8
Metadata
- Authors
- Feng, L., Wang, Y., Fu, Y., Li, T., & He, G.
- Affiliations
- Affiliated Hospital of Guizhou Medical University (CN)
- Shanxi Medical University (CN)
- Zhujiang Hospital (CN)
- Third Affiliated Hospital of Guangzhou Medical University (CN)
- Corresponding author
- Feng, Lei
- Li, Ting
- He, Guolin
- Venue
- Stem Cell Reviews and Reports
- Published
- 2024-01-03
- Volume
- 20
- Issue
- 3
- Pages
- 601-616
- ISSN
- 1550-8943 (ISSN-L)
- 2629-3269
- 2629-3277
- OpenAlex
- W4390571130
- Cited by
- 9
- References
- 214
- Citations by year
- 2025: 5 · 2024: 4
- FWCI
- 0.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Stem Cell Reviews and Reports (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (82200702, 82200959)
- Guangdong Basic and Applied Basic Research Foundation (2020A1515111111)
- Medical Research Foundation of Guangdong Province (B2022086)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- bioartificial liver, acute liver failure, stem cells, mesenchymal stem cells, stem cell secretome, liver transplantation alternatives, immunomodulation, anti-inflammatory activity, reactive oxygen species, anti-apoptotic effects, regenerative medicine
- MeSH terms
- Humans, Stem Cells, Liver Transplantation, Liver Failure, Acute, Liver, Artificial, Hepatocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Stem Cell-Based Strategies: The Future Direction of Bioartificial Liver Development. https://app.cochat.ai/papers/10.1007/s12015-023-10672-5
- The paper
- Feng, L., Wang, Y., Fu, Y., Li, T., & He, G. (2024). Stem Cell-Based Strategies: The Future Direction of Bioartificial Liver Development. Stem Cell Reviews and Reports. https://doi.org/10.1007/s12015-023-10672-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.